52 results
Page 2 of 3
6-K
EX-1.1
skg1s vf32jl
11 Feb 22
Current report (foreign)
5:29pm
6-K
EX-99.2
fhjohgrrh 0iuqf
2 Sep 21
Notice of Annual General Meeting of Shareholders
7:20am
6-K
EX-1.1
vtu9nepp1af
12 Apr 21
Vascular Biogenics Ltd. Prices Public Offering of Ordinary Shares and Pre-Funded Warrants
9:10am
6-K
EX-99.1
9xqu85 9c72irz0
12 Apr 21
Vascular Biogenics Ltd. Prices Public Offering of Ordinary Shares and Pre-Funded Warrants
9:10am
424B5
3mcgxg4dvbyshpdndya
12 Apr 21
Prospectus supplement for primary offering
9:07am
424B5
1vuvh
9 Apr 21
Prospectus supplement for primary offering
12:00am
6-K
EX-99.1
ekjygtm
15 Jan 21
Ordinary Share Purchase Agreement
7:01am
424B5
nqml1qb5bpm
15 Jan 21
Prospectus supplement for primary offering
7:00am
6-K
EX-99.2
i3j rxjsgxdie1wuav
28 May 20
Notice of Annual General Meeting of Shareholders
9:14am
6-K
EX-10.1
poqxqaj4grlh2c08bg
12 May 20
Current report (foreign)
12:04pm
6-K
EX-10.1
pwvtont18di ujd
11 May 20
VBL Therapeutics Announces $10.0 Million Registered Direct Offering
9:23am
6-K
EX-99.2
7bd3l3
1 Nov 19
Current report (foreign)
4:15pm
6-K
EX-10.1
nnuk0d38hf abu
17 May 19
Current report (foreign)
5:20pm
6-K
EX-99.2
bbwsz7qmg
15 Oct 18
Notice of Annual General Meeting of Shareholders
8:15am
6-K
EX-1.1
fhubt2wzm8aapnfgsw77
27 Jun 18
VBL Therapeutics Announces $15.5 Million Registered Direct Offering Priced At-the-Market
9:29am